(Q46122578)

19 December 2017

title

Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain (English)

1 reference

19 December 2017

1 reference

1 reference

5

1 reference

19 December 2017

Stefano Govoni

7

1 reference

19 December 2017

Massimo Allegri

9

1 reference

19 December 2017

Manuela De Gregori

object named as

Manuela De Gregori

1

0 references

Simona De Gregori

object named as

Simona De Gregori

3

0 references

Antonella Lisa

object named as

Antonella Lisa

6

0 references

author name string

Giulia Garbin

2

1 reference

19 December 2017

Cristina E Minella

4

1 reference

19 December 2017

Mario Regazzi

8

1 reference

19 December 2017

Guglielmina N Ranzani

10

1 reference

19 December 2017

publication date

19 May 2013

1 reference

19 December 2017

number of pages

8

1 reference

European Journal of Clinical Pharmacology

inferred from page(s)

published in

1 reference

19 December 2017

volume

69

1 reference

19 December 2017

issue

9

1 reference

19 December 2017

page(s)

1651-1658

1 reference

19 December 2017

Perioperative pain management.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Treatment of acute postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Catecholamine-O-Methyltransferase Polymorphisms Are Associated With Postoperative Pain Intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Genetic-epigenetic interaction modulates μ-opioid receptor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Current evidence for a genetic modulation of the response to analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Genetic modulation of the pharmacological treatment of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Ventilatory responses of healthy subjects to intravenous combinations of morphine and oxycodone under imposed hypercapnic and hypoxaemic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Patient-controlled analgesia in the management of postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Morphine-6-glucuronide: an analgesic of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Is morphine-3-glucuronide of therapeutic relevance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1523-7

Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli

21 January 2018

1 reference

12 December 2020

Controlling pain in the post-operative setting.

1 reference

12 December 2020

Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients

1 reference

12 December 2020

Genetic basis for individual variations in pain perception and the development of a chronic pain condition

1 reference

12 December 2020

Pharmacogenetics and postoperative pain: a new approach to improve acute pain management

1 reference

12 December 2020

Morphine analgesia in cancer pain: role of the glucuronides.

1 reference

12 December 2020

10.1007/S00228-013-1523-7

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017